Adrenal gland cancer is relatively rare, but often deadly because it usually has spread before detection. Moreover, today’s tests [MORE]
The cost of holding tissue in a frozen state is a major barrier to clinical biorepositories building their specimen [MORE]
Epidemiologists have long suspected a link between infertility and ovarian cancer, and researchers at Rush University Medical Center may [MORE]
Using laser capture micro-dissection and mass spectroscopy, researchers at Rensselaer Polytechnic Institute have been able to determine the proteomic “signatures [MORE]
For many years, neuroscientists have focused on the role amyloid beta plays in the plaques and tangles of neurons [MORE]
Researchers at Sweden’s Lund University recently reported on their use of protein microarrays to differentiate systemic lupus erythematosis from [MORE]
If cancer cells represent a kind of immortality (having lost their inability to die naturally), then it is not [MORE]
This past summer, life sciences instrument maker Illumina, Inc. (San Diego, CA) announced its founding of a collaboration [MORE]
Protein scientists in Germany and Japan have developed a new biochip that can detect proteins for specific diseases and [MORE]
In the end, all cancers have protein features, which may not be traced to genes or gene expression patterns. Post [MORE]
Labcyte, Inc (Sunnyvale, CA)—a company that pioneered acoustic methods for transferring liquids from pico to nanoliter containers—has now developed an [MORE]
If you put genomics, proetomics, metabolics, etc together, you’d have the “interactome” (i.e. the interaction of all the “omes”). By [MORE]
Daniel Alkon and colleagues at the Blanchette Rockefeller Neurosciences Institute in Morgantown, WV have developed a proteomic skin test that [MORE]
Denator AB (Gothenburg, Sweden) has licensed its protein stabilizer equipment to Harvard’s core proteomics laboratory for innovative translational technologies. Denator’s [MORE]